Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine.
SAN CARLOS, Calif., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the...
SAN CARLOS, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.41 | -2.07937877481 | 115.9 | 121.055 | 112.735 | 995952 | 115.90703818 | CS |
4 | 33.64 | 42.1289918597 | 79.85 | 121.055 | 77.21 | 1591418 | 111.00900349 | CS |
12 | 38.06 | 50.4573777012 | 75.43 | 121.055 | 70.45 | 963207 | 96.56578014 | CS |
26 | 46.27 | 68.8336804522 | 67.22 | 121.055 | 58.1 | 821763 | 83.87799937 | CS |
52 | 61.11 | 116.666666667 | 52.38 | 121.055 | 44.2 | 789695 | 73.4879872 | CS |
156 | 87.4 | 334.994250671 | 26.09 | 121.055 | 16.78 | 652329 | 52.21386643 | CS |
260 | 89.93 | 381.706281834 | 23.56 | 121.055 | 15.51 | 533706 | 48.79325855 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.